1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
EndoSd : An IgG glycan hydrolyzing enzyme in Streptococcus dysgalactiae subspecies dysgalactiae
(
- Contribution to journal › Article
- 2015
-
Mark
EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.
(
- Contribution to journal › Article
- 2013
-
Mark
EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein
(
- Contribution to journal › Article
- 2012
-
Mark
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by EndoS diminishes the pro-inflammatory properties of immune complexes from patients with SLE - a possible new treatment?
(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
The IgG specific endoglycosidase EndoS inhibits both cellular and complement mediated autoimmune hemolysis.
(
- Contribution to journal › Article
- 2009
-
Mark
Sugar-free antibodies--the bacterial solution to autoimmunity?
2009) 6th International Congress on Autoimmunity In Annals of the New York Academy of Sciences 1173. p.664-669(
- Contribution to journal › Article
- 2008
-
Mark
EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity
(
- Contribution to journal › Article
-
Mark
Enzymatically Generated Low Carbohydrate Antibodies as a Novel Treatment for Autoimmune Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Human IgG/FcgammaR Interactions Are Modulated by Streptococcal IgG Glycan Hydrolysis.
(
- Contribution to journal › Article